Parents are suing the defendants for negligent genetic counseling and testing that they allege precluded their ability to avoid having children with Duchenne.
While technology advances were perhaps less dramatic than in the year prior, several firms teased future releases that could have significant impacts.
Biobanks have been making strides in gathering data from more diverse populations this year while the evidence for the clinical utility of embryo PRS testing remains insufficient.
Genetic Variant in South American Indigenous Population Linked to Better Blood Cancer Drug Response
Premium
The variant, present in the NFKB1 gene and common in the Aymara community, could help guide treatment decisions, researchers reported at ASH.
Oxford Nanopore Technologies Sues BGI, Affiliates for Sequencing Technology Contract Breach
Among other demands, Oxford Nanopore asked the UK court to grant an injunction to prevent the sale and licensing of BGI's nanopore sequencing products.
The company also recently published multiple new clinical validation studies to support its quest for reimbursement.